Albania vs Fiji: Cause of death, by non-communicable diseases, ages 5-14, male
Albania
37.2%
in 2021
Fiji
36.6%
in 2021
Albania rank
83rd
Fiji rank
85th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Albania
- Fiji
How they compare
Albania currently reports 37.2% against 36.6% in Fiji, a difference of 0.6%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Fiji ahead.
Albania ranks 83rd and Fiji ranks 85th of 185 countries.
Across the 3 decades both report, Albania averaged higher in 2 and Fiji in 1.
Head to head by decade
| Decade | Albania | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.5% | 36.3% | 6.8% | Fiji |
| 2010s | 39.7% | 39.1% | 0.5% | Albania |
| 2020s | 40.1% | 39.1% | 1.0% | Albania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Albania or Fiji?
- Albania, at 37.2% against 36.6% in Fiji as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Albania and Fiji?
- 0.6%, with Albania ahead.
- How many years of comparable data are there for Albania and Fiji?
- 6 years are reported by both, from 2000 to 2021.
- How do Albania and Fiji rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Albania ranks 83rd and Fiji ranks 85th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.